Firm News: Drugs & Devices: Page 6

On August 25, 2016, Weitz & Luxenberg P.C. of counsel attorney Ellen Relkin is speaking at the LexisNexis complimentary CLE-eligible webinar “ADR for Complex Claims:Choosing and Using the Most Effective Resolution Instruments.” This 90-minute, audio-only webinar begins at 2:00 p.m. ET. This program is geared toward law firm professionals, state and local government representatives, and corporate…

Ellen Relkin, of counsel attorney for Weitz and Luxenberg’s team focusing on defective drugs and medical devices, has been filing lawsuits against the manufacturers of Invokana. Those manufacturers are Janssen Pharmaceuticals, and its affiliated companies Mitsubishi Tanabe Pharmaceuticals and Johnson & Johnson.  She spoke about the injuries this drug is causing, including diabetic ketoacidosis, with…

Weitz & Luxenberg is now accepting cases involving injuries from the nonsurgical permanent birth control device Essure. After implantation, a woman visits her physician three months later for a follow-up exam to confirm device placement. The law firm is interested in talking to those implanted with Essure devices who went to their follow-up doctor visit,…

W&L of counsel attorney Ellen Relkin will deliver a law update on Thursday, April 7, at Boardwalk Seminar 2016. Boardwalk Seminar 2016 is sponsored by the New Jersey Association for Justice. The event will be held over three days, beginning Wednesday, April 6, at Harrah’s Resort in Atlantic City, New Jersey. A certified New Jersey civil…

When physicians prescribe antibiotics to patients, they don’t expect their patients to develop a problem with their aorta. However, patients taking the fluoroquinolone class of antibiotics may do just that, based on elevated risk estimates found in two studies recently published in medical journals. W&L is now accepting clients who have suffered aortic dissection or…